@noca-natcan
The National Ovarian Cancer Audit (NOCA) is part of the National Cancer Audit Collaborating Centre (NATCAN). The aim of the NOCA is to evaluate the patterns of care and outcomes for patients with ovarian cancer in England and Wales.
Our QI intervention on emergency admission treatment rate has received responses from 49% of all GCSs in England and Wales.
Check live response log and more details on our website:
buff.ly/4unDj9d
#OvarianCancerAwarenessWeek
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
It's #OvarianCancerAwarenessMonth!
We're proud to work alongside @targetovarian.bsky.social and Ovarian Cancer Action, who are leading activities throughout the month to raise awareness and support patients and carers.
Together, we can drive change. 💙
@hqip.bsky.social @natcan-news.bsky.social
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
📢 New publication from NOCA Clinical Fellow Georgia Zachou: a systematic review finds that emergency ovarian cancer diagnoses are linked to more advanced disease and poorer outcomes, with a disproportionate impact on older and more deprived women.
Read more:
🔗https://buff.ly/jC02eSJ
📊 New for 2026! Explore the updated NOCA quarterly Data Dashboard. Review performance indicator results and data quality metrics for your cancer system now.
🔗 rcs-ceu.shinyapps.io/NOCA/
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
NATCAN has published its annual progress report! Read about NOCA on page 21!
The latest NOCA newsletter is out now! Read about the NOCA QI intervention, webinars and presentations, APPG parliament event and more here 👇
buff.ly/iCQJtNZ
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Poster of National Ovarian Cancer Audit (NOCA) for Quality Improvement Intervention: Improving Treatment Rates for Emergency Admissions Our Goals: Increase the proportion of women diagnosed with ovarian cancer after an emergency admission who receive any treatment (surgery and/or chemotherapy) Key Indicators 1. Proportion of women diagnosed with ovarian cancer following an emergency admission 2. Proportion of women diagnosed with ovarian cancer following an emergency admission who receive any treatment (surgery and/or chemotherapy) And more information on: - Why this matters - How we are supporting GCSs - What you can do Contact us: - natcan.org.uk/audits/ovarian - ovariancanceraudit@rcseng.ac.uk
🚨 NOCA has launched a Quality Improvement intervention to help improve treatment for women diagnosed with ovarian cancer following emergency admission.
A huge thank you to all the trusts who have responded!
Find more details here on responses so far : buff.ly/AyiWGrc
🎙️NATCAN will be hosting a webinar @londonglobalcancer.bsky.social in four weeks time!
📅 Webinar: 27 Nov | 🕥 10:30–12:00 GMT
Find out more about the agenda, and join us to explore how to drive improvements in cancer care.
🔗 buff.ly/Murx42E
#LondonGlobalCancerWeek #LGCW2025
National Ovarian Cancer Audit State of the Nation Patient and Public Report 2025 An audit of care received by women diagnosed with ovarian cancer between 1 January 2022 and 31 December 2022 in England and 1 January 2022 and 31 December 2023 in Wales. Published September 2025
Have you read the 2025 NOCA State of the Nation Patient and Public Report?
Learn more about ovarian cancer and key findings about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/x99UfX3
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
👏 Prof Agnieszka Michael, NOCA Clinical Lead, presented at Royal College of Radiologists webinar on 17 October!
She shared insights on the NOCA State of the Nation report and upcoming QI Intervention.
Missed it? Catch up here: buff.ly/RsaLo4B
Screenshot from the webinar: Dr Georgia Zachou presenting a summary of the findings from the NOCA 2025 State of the Nation Report.
🎤 NATCAN hosted a State of the Nation 2025 webinar on 13 October! 👏
Thanks to NOCA Clinical Fellow, Dr Georgia Zachou, who shared valuable insights on the NOCA report.
Missed it? Catch up here: buff.ly/OQMK5q6
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
📊 Our October Quarterly Data Dashboard is now live! This includes the latest English data up to March 2024. Data from our 2025 State of the Nation Report is also live on the dashboard! 👇
www.natcan.org.uk/data/
@hqip.bsky.social @targetovarian.bsky.social @natcan-news.bsky.social
Did you know❓Approximately seven out of ten women in England, and three out of four in Wales, survived at least one year after ovarian cancer diagnosis.
📲Read the report by @noca-natcan.bsky.social @natcan-news.bsky.social @hqip.bsky.social: www.hqip.org.uk/resource/633...
#OvarianCancer #Cancer
🚀 The new NATCAN website is now live! Find details of NOCA here, including the NOCA State of the Nation Report 2025:
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023
buff.ly/oLr7Z7J
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
💻 Upcoming webinars💻
Join us on Monday 13 October for our NATCAN webinars, chaired by Prof Ajay Aggarwal, where we will be sharing key findings from the 2025 SotN reports.
To book tickets and find out more, visit our website👇
buff.ly/ngyfOse
Admission is free.
📊 New! Explore the 2025 NOCA State of the Nation Dashboard and check performance indicator results for your cancer system.
buff.ly/dcBGnFG
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
Our new website is live! 🎉
All 10 national cancer audits are now in one place: bowel, OG, NHL, lung, ovarian, kidney, prostate, pancreatic, primary breast & metastatic breast.
Plus refreshed QI & new sections have been added, check it out here 👉 natcan.org.uk
The latest NOCA newsletter is out now! Read about the NOCA State of the Nation Report 2025 published last week, new NATCAN website, NOCA QI intervention and more here 👇
buff.ly/C2XYSW7
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
📢 The 2025 NOCA State of the Nation Report and Patient and Public Report are now live along with a data dashboard!
Read about patients diagnosed in England in 2022 and in Wales in 2022-2023 here:
🔗 buff.ly/dOTZClC
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
A photo of Prof Agnieszka Michael presenting at the BGCS meeting.
👏 Thank you to Professor Agnieszka Michael, NOCA Clinical Lead, for a fantastic presentation at #BGCS2025.
Great to see such strong engagement from the gynae-oncology community! 🙌
@hqip.bsky.social @natcan-news.bsky.social @targetovarian.bsky.social
📊 Our July Quarterly Dashboard is now live!
Explore the latest data insights and performance indicator updates.
🔗 buff.ly/nkA9hR6
@natcan-news.bsky.social @targetovarian.bsky.social
Professor Agnieszka Michael, NOCA Clinical Lead, will speak at #BGCS2025 conference, presenting key findings from our upcoming 2025 State of the Nation report (📅 publication on 11th Sept) and sharing insights on the NOCA QI intervention! 💡
Book to join on 9-11 July
👉https://bit.ly/3EQitw0
The latest NOCA newsletter is out now! Read about the recent NOCA webinar, QI intervention and more here 👇
www.natcan.org.uk/news/noca-ne...
@natcan-news.bsky.social
@targetovarian.bsky.social
👏 Great news for the National Ovarian Cancer Audit and the other NATCAN audits!
The National Ovarian Cancer Audit is proud to support #WorldOvarianCancerDay!
Follow us to find out more about the impact of the audit on outcomes for women with ovarian cancer.
Visit the NOCA website for more info: www.natcan.org.uk/audits/ovari...
@targetovarian.bsky.social
The latest NOCA quarterly data dashboard is live on our website! This now includes downloadable reports for each trust. Take a look at your results here:
bit.ly/4gJ3O43
@natcan-news.bsky.social @targetovarian.bsky.social